Tandem Diabetes Care, Inc. (TNDM)
Data as of Nov 3, 11:22 AM ETPrices may be delayedHow our data works
Res / Sup are automatic swing levels for educational reference only — not signals or advice.
Prices may be delayed. For informational purposes only — not investment advice.
TNDM key stats
TNDM GlowScore: Quiet
A 0–100 read on today's activity from volume, momentum and intraday range. Not a buy or sell signal.
About Tandem Diabetes Care, Inc.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on the Sigi tubeless patch pump. Tandem is also developing a fully closed-loop algorithm for its pumps. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 3 to 7 days.
What's moving TNDM today
Updated November 3, 2026As of November 3, 2026, Tandem Diabetes Care, Inc. (TNDM) stock fell to $18.16, down 2.73% (-$0.51) versus the previous close. On the day, shares have traded between $18.06 and $18.67. That puts TNDM in the lower third of its 52-week range of $12.26 to $29.65. Tandem Diabetes Care, Inc. operates in the surgical & medical instruments & apparatus space and carries a market capitalization of roughly $1.30 billion, with about 403.8K shares changing hands.
Latest TNDM news
- 3 of Wall Street’s favorite stocks that concern usYahoo Finance· Nov 3, 6:01 AM ET
- Tandem Diabetes Care Announces Upcoming Conference PresentationsYahoo Finance· Oct 30, 4:05 PM ET
- Rapid Micro Biosystems, Inc. (RPID) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseYahoo Finance· Oct 30, 9:00 AM ETRPID
- Tandem Diabetes Care, Inc. (TNDM) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseYahoo Finance· Oct 29, 9:00 AM ET
- 3 Russell 2000 stocks that fall shortYahoo Finance· Oct 28, 2:14 PM ET
- Tandem Diabetes Care (TNDM) Stock May Be Underpriced Given Its Sales BaseYahoo Finance· Oct 27, 2:09 AM ET
- Is it the Right Time to Hold TNDM Stock in Your Portfolio?Yahoo Finance· Oct 9, 9:05 AM ET
- Flutter upgraded, AppFolio downgraded: Wall Street's top analyst callsYahoo Finance· Oct 7, 10:00 AM ET
Source: Yahoo Finance RSS · Updated November 3, 2026
Want TNDM headlines, alerts and AI research in one place? Create a free account →
TNDM buzz on Stocktwits
13,901 watchers$TNDM they have the best algorithm of any insulin pump delivery system and trust is all that matters when your life depends on it. They are building a loyal customer base much like $AAPL who will no doubt have to get into the medical industry sooner or later and microdosing is…
@fustuyst· Oct 29, 12:04 PM ET
$TNDM keep watch if this holds above 18.34
@StockScanners· Oct 26, 9:32 PM ET
$TNDM if the democrats control the coming congress this might climb alot
@labibaouf· Oct 26, 6:20 PM ET· Bullish
@BMWLTWM3 I remember when the 365 got approved by the FDA, I thought we'd hit the moon the following Monday, Nope it went down. Not sure this will ever give us the great return that $DXCM and $TNDM gave us when they popped.
@Punpire· Oct 26, 4:41 PM ET
$TNDM solid entry point for a starter position.
@Don_Heisenberg· Oct 18, 11:47 AM ET
Source: Stocktwits. User posts are opinions, not verified facts. See what's trending →
TNDM Congress & insider trades
Congress amounts are the disclosed ranges; filings can lag the trade date by up to 45 days.
AI research on TNDM
Get an instant AI breakdown of the bull & bear case, key risks, and what analysts are watching.
Not financial advice. This page is for educational purposes only. Data comes from third-party sources, may be delayed or incomplete, and should not be the basis of any investment decision.